1. Home
  2. ELME vs BHVN Comparison

ELME vs BHVN Comparison

Compare ELME & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELME
  • BHVN
  • Stock Information
  • Founded
  • ELME 1960
  • BHVN 2013
  • Country
  • ELME United States
  • BHVN United States
  • Employees
  • ELME N/A
  • BHVN N/A
  • Industry
  • ELME Real Estate Investment Trusts
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELME Real Estate
  • BHVN Health Care
  • Exchange
  • ELME Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • ELME 1.5B
  • BHVN 1.7B
  • IPO Year
  • ELME N/A
  • BHVN 2017
  • Fundamental
  • Price
  • ELME $16.79
  • BHVN $15.33
  • Analyst Decision
  • ELME Hold
  • BHVN Strong Buy
  • Analyst Count
  • ELME 5
  • BHVN 14
  • Target Price
  • ELME $14.25
  • BHVN $49.23
  • AVG Volume (30 Days)
  • ELME 916.6K
  • BHVN 2.5M
  • Earning Date
  • ELME 11-03-2025
  • BHVN 11-11-2025
  • Dividend Yield
  • ELME 4.31%
  • BHVN N/A
  • EPS Growth
  • ELME N/A
  • BHVN N/A
  • EPS
  • ELME N/A
  • BHVN N/A
  • Revenue
  • ELME $245,911,000.00
  • BHVN N/A
  • Revenue This Year
  • ELME N/A
  • BHVN N/A
  • Revenue Next Year
  • ELME $8.14
  • BHVN $2,078.82
  • P/E Ratio
  • ELME N/A
  • BHVN N/A
  • Revenue Growth
  • ELME 4.59
  • BHVN N/A
  • 52 Week Low
  • ELME $13.95
  • BHVN $12.79
  • 52 Week High
  • ELME $18.08
  • BHVN $54.98
  • Technical
  • Relative Strength Index (RSI)
  • ELME 51.07
  • BHVN 51.00
  • Support Level
  • ELME $16.59
  • BHVN $14.98
  • Resistance Level
  • ELME $16.90
  • BHVN $17.61
  • Average True Range (ATR)
  • ELME 0.13
  • BHVN 0.96
  • MACD
  • ELME -0.02
  • BHVN 0.12
  • Stochastic Oscillator
  • ELME 57.71
  • BHVN 45.89

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: